Biden’s Advisors: A Drug-Pricing Reading List

December 2020

A new administration means a fresh set of policy approaches but it also means new people who can guide the process of turning those approaches into legislative and regulatory action.

President-elect Biden is building out that team, which now includes California Attorney General Xavier Becerra, nominated to be Secretary of Health and Human Services, and Center for American Progress President Neera Tanden, picked to be director of the Office of Management and Budget, among others.

Curious about what they and their colleagues have been saying about drug prices and drug regulation? Check out our “reading list” from some of Biden’s confirmed and potential policy advisors.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Content provided by W2O Group’s Value Report newsletter. Subscribe to the weekly newsletter here.

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO